Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:968-969 (3 May), doi:10.1136/bmj.39540.657928.BE (published 10 April 2008)
Urinary spot protein:creatinine ratio can reliably rule out proteinuria in pregnancy
| The first 150 words of the full text of this article appear below. |
Pre-eclampsia is a global problem—it affects 2-8% of pregnancies, and an estimated 8.3 million women develop the disease each year. For developing countries, the priority is preventing maternal deaths from multiorgan complications of the disease. The difference in case fatality rates from eclampsia between developing countries and developed countries (5.2% v 0.72%) suggests that mortality is easily avoidable.1 In developed countries where death is rarer, research is directed towards improving prediction and prevention of pre-eclampsia and minimising morbidity. Accurate diagnosis is needed to accomplish this. In the accompanying systematic review, Côté and colleagues assess urinary spot protein:creatinine and albumin:creatinine ratios as diagnostic tests for significant proteinuria in women with hypertension in pregnancy.2
Pre-eclampsia is a multiorgan syndrome, the clinical characteristics of which may include kidney, liver, and cerebral damage, an altered coagulant state, and fetal growth restriction.3 It is defined by two imperfect measures of end organ involvement—hypertension and proteinuria.4
Lucy C Chappell, senior lecturer in maternal and fetal medicine, Andrew H Shennan, professor of obstetrics
1 Division of Reproduction and Endocrinology, Kings College, London SE1 7EH
lucy.chappell@kcl.ac.uk
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.